Recent developments in the virus therapy of cancer.
Cancer is one of the leading causes of death in the United States. Although there has been significant progress in the areas of cancer etiology, diagnostic techniques, and cancer prevention, adequate therapeutic approaches for many cancers have lagged behind. One promising line of investigation is the virus therapy of cancer. This approach entails the use of viruses, such as retroviruses, adenovirus, and vaccinia virus, to modify tumor cells so that they become more susceptible to being killed by the host immune response, chemotherapeutic agents, or programmed cell death. This review discusses recent advances in the virus therapy of cancer from both basic science and clinical perspectives. Given the potential of viruses to kill tumor cells directly or transduce desired gene products to allow a vigorous host antitumor immune response, the virus therapy of cancer holds great promise in the treatment of cancer.
Steele
T A
TA
Mercer University School of Medicine, Macon, Georgia 31207, USA. Timothy.Steele@dsmu.edu
D000818:Animals; D001691:Biological Therapy; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014765:Viral Vaccines; D014780:Viruses
D014765:Viral Vaccines